- Home
- OMH vs LSTA Comparison
OMH vs LSTA Comparison
Compare OMH & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- LSTA
- Stock Information
- Founded
- OMH 2015
- LSTA 1980
- Country
- OMH Singapore
- LSTA United States
- Employees
- OMH N/A
- LSTA N/A
- Industry
- OMH Real Estate
- LSTA Misc Health and Biotechnology Services
- Sector
- OMH Finance
- LSTA Health Care
- Exchange
- OMH Nasdaq
- LSTA Nasdaq
- Market Cap
- OMH 25.2M
- LSTA 20.9M
- IPO Year
- OMH 2023
- LSTA N/A
- Fundamental
- Price
- OMH $0.84
- LSTA $2.02
- Analyst Decision
- OMH Hold
- LSTA Strong Buy
- Analyst Count
- OMH 1
- LSTA 2
- Target Price
- OMH N/A
- LSTA $23.50
- AVG Volume (30 Days)
- OMH 174.2K
- LSTA 146.7K
- Earning Date
- OMH 10-30-2025
- LSTA 11-06-2025
- Dividend Yield
- OMH N/A
- LSTA N/A
- EPS Growth
- OMH N/A
- LSTA N/A
- EPS
- OMH N/A
- LSTA N/A
- Revenue
- OMH $7,976,578.00
- LSTA $1,070,000.00
- Revenue This Year
- OMH $28.40
- LSTA N/A
- Revenue Next Year
- OMH $23.07
- LSTA N/A
- P/E Ratio
- OMH N/A
- LSTA N/A
- Revenue Growth
- OMH 117.53
- LSTA N/A
- 52 Week Low
- OMH $0.59
- LSTA $1.87
- 52 Week High
- OMH $5.10
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- OMH 23.06
- LSTA 34.00
- Support Level
- OMH $0.79
- LSTA $1.92
- Resistance Level
- OMH $1.57
- LSTA $2.28
- Average True Range (ATR)
- OMH 0.10
- LSTA 0.19
- MACD
- OMH -0.04
- LSTA -0.04
- Stochastic Oscillator
- OMH 6.28
- LSTA 8.24
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.